Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation
Open Access
- 16 June 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in The European Journal of Health Economics
- Vol. 15 (6), 577-589
- https://doi.org/10.1007/s10198-013-0495-y
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- New DrugsDeutsches Ärzteblatt international, 2012
- Évaluation du service médical rendu des médicaments par la Commission de la TransparenceJournal Français d'Ophtalmologie, 2008
- An update on the first decade of the European centralized procedure: how many innovative drugs?British Journal of Clinical Pharmacology, 2006